The Establishment of the Integration of Surgery and Postoperative Intensive Recovery of Patients With CSM

Sponsor
Peking University Third Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04947891
Collaborator
(none)
130
1
36.5
3.6

Study Details

Study Description

Brief Summary

This study aims to establish the specialist consensus of the integration of posterior approach surgical treatment and postoperative intensive recovery management for CSM or OPLL patients, and verify its safety, practicability and reliability.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Intensive recovery management

Detailed Description

In order to establish the specialist consensus of the integration of posterior approach surgical treatment and postoperative intensive recovery management, and verify its safety, practicability and reliability, this study enrolled 130 patients with CSM or OPLL undergoing C3-7 open-door laminoplasty. Patients are divided in two groups randomly. The study group has 80 patients, treated with postoperative intensive recovery management, and the control group has 50 patients. The data is collected preoperatively, at 3-month follow-up and 1-year follow-up.

Study Design

Study Type:
Observational
Actual Enrollment :
130 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Establishment of the Integration of Posterior Approach Surgical Treatment and Postoperative Intensive Recovery Management of Patients With Degenerative Cervical Spine Myelopathy
Actual Study Start Date :
Dec 6, 2017
Actual Primary Completion Date :
Jun 15, 2020
Actual Study Completion Date :
Dec 20, 2020

Arms and Interventions

Arm Intervention/Treatment
Study group

Patients will be treated with intensive recovery method after surgery.

Procedure: Intensive recovery management
Intensive recovery management includes 3 parts: (1) Preoperative analgesia and airway evaluation. (2) The protection and reconstruction of the musculo-ligamentous complex during the surgery, the safe intubation, and the local infiltration anesthesia during surgery. (3) Collar free, multimodal analgesia, airway management, and early recovery after surgery.

Control group

Patients will be treated with regular recovery method after surgery.

Outcome Measures

Primary Outcome Measures

  1. Cervical spine mechanical analysis [Preoperation to 1 year after surgery.]

    The ROM and multi-dimensional mechanical analysis of cervical spine before surgery, at 3-month postoperative follow-up and 1-year follow

  2. Cervical spine functions [Preoperation to 1 year after surgery.]

    NDI score and JOACMEQ score before surgery, at 3-month postoperative follow-up and 1-year follow

Secondary Outcome Measures

  1. Outcome of quality of life [Preoperation to 1 year after surgery.]

    EQ-5D score before surgery, at 3-month postoperative follow-up and 1-year follow

  2. Outcome of pain [Preoperation to 1 year after surgery.]

    VAS score before surgery, at 3-month postoperative follow-up and 1-year follow

  3. Neurological outcome [Preoperation to 1 year after surgery.]

    mJOA score before surgery, at 3-month postoperative follow-up and 1-year follow

Eligibility Criteria

Criteria

Ages Eligible for Study:
17 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • (1) Age: 18~70 years. (2) Diagnosed as CSM or OPLL. (3) Going to receive C3-C7 open-door laminoplasty. (4) Agree to join this study and sign the informed consent.
Exclusion Criteria:
  • (1) Anterior and posterior combined surgery. (2) Posterior laminoplasty combined fusion. (3) Severe osteoporosis. (4) Morbid obesity. (5) patients with mental disorder. (6) patients with previous history of cervical spine surgery. (7) Abnormal laboratory report of liver function, kidney function and hematologic system.(8) Poor compliance. (9) Patients with other surgical contraindications. (10) Patients with intemperance or taking drugs. (11) Patients who joined other study within the last 3 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Feifei Zhou Beijing Beijing China 100191

Sponsors and Collaborators

  • Peking University Third Hospital

Investigators

  • Study Chair: Feifei Zhou, M.D., Peking University Third Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT04947891
Other Study ID Numbers:
  • M2017310
First Posted:
Jul 1, 2021
Last Update Posted:
Jul 1, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Peking University Third Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 1, 2021